Independent Director · Zenas BioPharma, Inc. (ZBIO)

Chair, Compensation Committee · Chair, Science and Technology Committee

John Orloff, M.D — Zenas BioPharma Director Compensation (2025)

Fiscal year 2025 director compensation for John Orloff, M.D at Zenas BioPharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 16, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Zenas BioPharma Director Compensation Table · the one fiscal year held
In US dollars, as Zenas BioPharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,852—$169,023—$226,875

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zenas BioPharma, Inc. DEF 14A filed March 16, 2026, accession 0001104659-26-028062, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Zenas BioPharma pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation (Chair) · Science and Technology (Chair)

The rest of the Zenas BioPharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Hongbo Lu, Ph.DIndependent Director$216,949
Jake NunnIndependent Director$219,023
James BoylanLead Independent Director$241,873
Leon O. Moulder JrChair of the Board$0
Patricia AllenIndependent Director$229,023
Patrick EnrightIndependent Director$225,023
Tomas KiselakIndependent Director$216,949

The full Zenas BioPharma compensation record

free company brief

This page is one director within Zenas BioPharma's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy